Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Formyl Peptide Receptor 2 Plays a Deleterious Role During Influenza A Virus Infections.

Tcherniuk S, Cenac N, Comte M, Frouard J, Errazuriz-Cerda E, Galabov A, Morange PE, Vergnolle N, Si-Tahar M, Alessi MC, Riteau B.

J Infect Dis. 2016 Jul 15;214(2):237-47. doi: 10.1093/infdis/jiw127. Epub 2016 Mar 30.

PMID:
27034344
2.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

3.

The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus.

Rahman F, Chebbo M, Courtin N, Fotso Fotso A, Alessi MC, Riteau B.

Int J Mol Sci. 2018 May 8;19(5). pii: E1400. doi: 10.3390/ijms19051400.

4.

FPR2: A Novel Promising Target for the Treatment of Influenza.

Alessi MC, Cenac N, Si-Tahar M, Riteau B.

Front Microbiol. 2017 Sep 5;8:1719. doi: 10.3389/fmicb.2017.01719. eCollection 2017. Review.

5.

Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.

Courtin N, Fotso AF, Fautrad P, Mas F, Alessi MC, Riteau B.

Antiviral Res. 2017 Jul;143:252-261. doi: 10.1016/j.antiviral.2017.05.001. Epub 2017 May 5.

6.

Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.

Hanson J, Ferreirós N, Pirotte B, Geisslinger G, Offermanns S.

Biochem Pharmacol. 2013 Jun 15;85(12):1795-802. doi: 10.1016/j.bcp.2013.04.019. Epub 2013 May 1.

PMID:
23643932
7.

Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.

Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC, Perretti M, Flower RJ.

J Immunol. 2010 Mar 1;184(5):2611-2619. doi: 10.4049/jimmunol.0903526. Epub 2010 Jan 27. Erratum in: J Immunol. 2011 Feb 15;186(4):2684-5.

8.

Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-β-STAT3-dependent pathway.

Ampomah PB, Moraes LA, Lukman HM, Lim LHK.

FASEB J. 2018 Mar;32(3):1468-1478. doi: 10.1096/fj.201700584RR. Epub 2018 Jan 3.

PMID:
29127186
9.

The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.

Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, Komase K, Nobusawa E, Maenaka K, Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M, Takeda M.

J Virol. 2014 May;88(10):5608-16. doi: 10.1128/JVI.03677-13. Epub 2014 Mar 5.

10.

The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.

Skovbakke SL, Heegaard PM, Larsen CJ, Franzyk H, Forsman H, Dahlgren C.

Biochem Pharmacol. 2015 Jan 15;93(2):182-95. doi: 10.1016/j.bcp.2014.11.004. Epub 2014 Nov 14.

PMID:
25462815
11.

The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.

Holdfeldt A, Skovbakke SL, Winther M, Gabl M, Nielsen C, Perez-Gassol I, Larsen CJ, Wang JM, Karlsson A, Dahlgren C, Forsman H, Franzyk H.

J Biol Chem. 2016 Sep 16;291(38):19888-99. doi: 10.1074/jbc.M116.736850. Epub 2016 Jul 15.

12.

Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis.

Arora S, Lim W, Bist P, Perumalsamy R, Lukman HM, Li F, Welker LB, Yan B, Sethi G, Tambyah PA, Fairhurst AM, Alonso S, Lim LH.

Cell Death Differ. 2016 Jul;23(7):1243-56. doi: 10.1038/cdd.2016.19. Epub 2016 Mar 4.

13.

Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.

Betts RJ, Mann TS, Henry PJ.

J Pharmacol Exp Ther. 2012 Dec;343(3):725-35. doi: 10.1124/jpet.112.196485. Epub 2012 Sep 17.

PMID:
22988062
14.

Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.

Gastardelo TS, Cunha BR, Raposo LS, Maniglia JV, Cury PM, Lisoni FC, Tajara EH, Oliani SM.

PLoS One. 2014 Dec 9;9(12):e111317. doi: 10.1371/journal.pone.0111317. eCollection 2014.

15.

FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.

Gabl M, Holdfeldt A, Sundqvist M, Lomei J, Dahlgren C, Forsman H.

Biochem Pharmacol. 2017 Dec 1;145:114-122. doi: 10.1016/j.bcp.2017.08.018. Epub 2017 Aug 30.

PMID:
28855087
16.

Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation.

Musiol A, Gran S, Ehrhardt C, Ludwig S, Grewal T, Gerke V, Rescher U.

MBio. 2013 Nov 5;4(6):e00608-13. doi: 10.1128/mBio.00608-13.

17.

Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.

LeMessurier KS, Lin Y, McCullers JA, Samarasinghe AE.

Antiviral Res. 2016 Sep;133:208-17. doi: 10.1016/j.antiviral.2016.08.013. Epub 2016 Aug 13.

18.

Non-peptide ligand binding to the formyl peptide receptor FPR2--A comparison to peptide ligand binding modes.

Stepniewski TM, Filipek S.

Bioorg Med Chem. 2015 Jul 15;23(14):4072-81. doi: 10.1016/j.bmc.2015.03.062. Epub 2015 Mar 28.

PMID:
25882522
19.

Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.

Wang H, Anthony D, Yatmaz S, Wijburg O, Satzke C, Levy B, Vlahos R, Bozinovski S.

Clin Sci (Lond). 2017 Aug 24;131(18):2347-2362. doi: 10.1042/CS20171006. Print 2017 Sep 15.

PMID:
28779028
20.

Influenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.

Nakamura S, Horie M, Daidoji T, Honda T, Yasugi M, Kuno A, Komori T, Okuzaki D, Narimatsu H, Nakaya T, Tomonaga K.

J Virol. 2015 Dec 4;90(4):1788-801. doi: 10.1128/JVI.02246-15. Print 2016 Feb 15.

Supplemental Content

Support Center